Video – Page 2 – Race Oncology

Category: Video

Pitt St Research interview with Race Oncology’s CEO Phil Lynch & CSO Dr Daniel Tillett

Daniel Tillett Featured, Media Release, Video Biotech, Race Oncology, Zantrene

Race Oncology June 2022 Quarterly Investor Briefing

Race Oncology June 2022 Quarterly Investor Briefing

Daniel Tillett Featured, Media Release, Video

Race Oncology CEO Phillip Lynch and CSO Dr Daniel Tillett present Race’s June 2022 Quarterly Investor Briefing followed by a Q&A session.

GC Investment Showcase 2022

Race Oncology Presents at the Gold Coast Investor Showcase 2022

Daniel Tillett Featured, Video cancer, Race Oncology, Zantrene

Race CMO Dr David Fuller Talks to Proactive about latest Zantrene Trial News

Daniel Tillett Featured, Media Release, Video AML, Leukaemia, Race Oncology, Zantrene

WIN News talks to Race Oncology

Cancer Drug Trial

Daniel Tillett Featured, Media Release, Video cancer, Race Oncology, Zantrene

Race Oncology CSO Dr Daniel Tillett talks to WIN Television News about Race Oncology’s research collaboration with the University of Wollongong.

Race CEO Phil Lynch Talks with Proactive at the ASX Small and Mid-Cap Conference

Daniel Tillett Featured, Media Release, Video AML, Biotech, cancer, Race Oncology, Zantrene

Race Oncology ASX Small and Mid Cap Conference Presentation

Daniel Tillett Featured, Media Release, Video AML, cancer, Race Oncology, Zantrene

Proactive interview with Dr Daniel Tillett

CSO Dr Daniel Tillett talks to Proactive about recent kidney cancer results

Daniel Tillett Featured, Video Bisantrene, cancer, drug, Patent, Race Oncology, Zantrene

CSO Dr Daniel Tillett talks to Small Caps about Race Oncology’s Plans for 2022 and beyond

Daniel Tillett Featured, Media Release, Video cancer, Race Oncology

Race Oncology Q&A Session

Daniel Tillett Featured, Video

Race Oncology

At the heart of cancer care